0 Bewertungen
ID

39891

Beschreibung

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.; ODM derived from: https://clinicaltrials.gov/show/NCT01258439

Link

https://clinicaltrials.gov/show/NCT01258439

Stichworte

Versionen (1)
  1. 29.02.20 29.02.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

29. Februar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility HIV NCT01258439

    Englisch

    Eligibility HIV NCT01258439

    1 Formulare  
    1. StudyEvent: Eligibility
      1. Eligibility HIV NCT01258439
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    provision of signed, informed consent
    Beschreibung

    Informed Consent

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    age >18 years
    Beschreibung

    Age

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    hiv infection documented by hiv antibody test and western blot prior to study entry
    Beschreibung

    HIV Infections | HIV Antibody Measurement | Western blot for HIV

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0019693
    UMLS CUI [2]
    C3714540
    UMLS CUI [3]
    C0860963
    no previous art or no art for 6 months prior to randomisation
    Beschreibung

    Antiretroviral therapy Absent

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1963724
    UMLS CUI [1,2]
    C0332197
    cd4+ count of <500 cells/mm or viral load >10,000 copies/ml within 60 days prior to randomisation
    Beschreibung

    CD4+ Count | Viral load measurement

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0243009
    UMLS CUI [2]
    C1261478
    no genotypic resistance to raltegravir, tenofovir/emtricitabine, darunavir, ritonavir
    Beschreibung

    Absence Resistance Genotypic Raltegravir | Absence Resistance Genotypic Tenofovir | Absence Resistance Genotypic Emtricitabine | Absence Resistance Genotypic Darunavir | Absence Resistance Genotypic Ritonavir

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0332197
    UMLS CUI [1,2]
    C1514892
    UMLS CUI [1,3]
    C0017431
    UMLS CUI [1,4]
    C1871526
    UMLS CUI [2,1]
    C0332197
    UMLS CUI [2,2]
    C1514892
    UMLS CUI [2,3]
    C0017431
    UMLS CUI [2,4]
    C0384228
    UMLS CUI [3,1]
    C0332197
    UMLS CUI [3,2]
    C1514892
    UMLS CUI [3,3]
    C0017431
    UMLS CUI [3,4]
    C0909839
    UMLS CUI [4,1]
    C0332197
    UMLS CUI [4,2]
    C1514892
    UMLS CUI [4,3]
    C0017431
    UMLS CUI [4,4]
    C1435444
    UMLS CUI [5,1]
    C0332197
    UMLS CUI [5,2]
    C1514892
    UMLS CUI [5,3]
    C0017431
    UMLS CUI [5,4]
    C0292818
    body mass index less than 30kg/m2
    Beschreibung

    Body mass index

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1305855
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    primary hiv infection within the last 6 months
    Beschreibung

    Primary HIV infection Recent

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1142553
    UMLS CUI [1,2]
    C0332185
    active infection or opportunistic illness within the previous 30 days
    Beschreibung

    Communicable Disease Recent | Opportunistic Infection Recent

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0009450
    UMLS CUI [1,2]
    C0332185
    UMLS CUI [2,1]
    C0029118
    UMLS CUI [2,2]
    C0332185
    use of any medication contra-indicated with ritonavir-boosted darunavir or raltegravir
    Beschreibung

    Pharmaceutical Preparation Contraindicated Darunavir+Ritonavir | Pharmaceutical Preparation Contraindicated Raltegravir

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C1444657
    UMLS CUI [1,3]
    C1976853
    UMLS CUI [2,1]
    C0013227
    UMLS CUI [2,2]
    C1444657
    UMLS CUI [2,3]
    C1871526
    use of lipid-lowering therapy
    Beschreibung

    Lipid-lowering therapy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0585943
    diabetes mellitus (fasting glucose >7.0mml/l or a prior diagnosis of diabetes)
    Beschreibung

    Diabetes Mellitus | Glucose measurement, fasting

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0011849
    UMLS CUI [2]
    C0202045
    use of oral prednisolone > 7.5mg daily or equivalent
    Beschreibung

    Oral prednisolone U/day | Equivalent

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0358513
    UMLS CUI [1,2]
    C0456683
    UMLS CUI [2]
    C0205163
    pregnancy or breast feeding
    Beschreibung

    Pregnancy | Breast Feeding

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    proven hypersensitivity to one or more components of the study meal
    Beschreibung

    Hypersensitivity Component Study Meal

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C1705248
    UMLS CUI [1,3]
    C0008972
    UMLS CUI [1,4]
    C1998602
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility HIV NCT01258439

    1 Formulare
    1. StudyEvent: Eligibility
      1. Eligibility HIV NCT01258439
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Informed Consent
    Item
    provision of signed, informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Age
    Item
    age >18 years
    boolean
    C0001779 (UMLS CUI [1])
    HIV Infections | HIV Antibody Measurement | Western blot for HIV
    Item
    hiv infection documented by hiv antibody test and western blot prior to study entry
    boolean
    C0019693 (UMLS CUI [1])
    C3714540 (UMLS CUI [2])
    C0860963 (UMLS CUI [3])
    Antiretroviral therapy Absent
    Item
    no previous art or no art for 6 months prior to randomisation
    boolean
    C1963724 (UMLS CUI [1,1])
    C0332197 (UMLS CUI [1,2])
    CD4+ Count | Viral load measurement
    Item
    cd4+ count of <500 cells/mm or viral load >10,000 copies/ml within 60 days prior to randomisation
    boolean
    C0243009 (UMLS CUI [1])
    C1261478 (UMLS CUI [2])
    Absence Resistance Genotypic Raltegravir | Absence Resistance Genotypic Tenofovir | Absence Resistance Genotypic Emtricitabine | Absence Resistance Genotypic Darunavir | Absence Resistance Genotypic Ritonavir
    Item
    no genotypic resistance to raltegravir, tenofovir/emtricitabine, darunavir, ritonavir
    boolean
    C0332197 (UMLS CUI [1,1])
    C1514892 (UMLS CUI [1,2])
    C0017431 (UMLS CUI [1,3])
    C1871526 (UMLS CUI [1,4])
    C0332197 (UMLS CUI [2,1])
    C1514892 (UMLS CUI [2,2])
    C0017431 (UMLS CUI [2,3])
    C0384228 (UMLS CUI [2,4])
    C0332197 (UMLS CUI [3,1])
    C1514892 (UMLS CUI [3,2])
    C0017431 (UMLS CUI [3,3])
    C0909839 (UMLS CUI [3,4])
    C0332197 (UMLS CUI [4,1])
    C1514892 (UMLS CUI [4,2])
    C0017431 (UMLS CUI [4,3])
    C1435444 (UMLS CUI [4,4])
    C0332197 (UMLS CUI [5,1])
    C1514892 (UMLS CUI [5,2])
    C0017431 (UMLS CUI [5,3])
    C0292818 (UMLS CUI [5,4])
    Body mass index
    Item
    body mass index less than 30kg/m2
    boolean
    C1305855 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Primary HIV infection Recent
    Item
    primary hiv infection within the last 6 months
    boolean
    C1142553 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    Communicable Disease Recent | Opportunistic Infection Recent
    Item
    active infection or opportunistic illness within the previous 30 days
    boolean
    C0009450 (UMLS CUI [1,1])
    C0332185 (UMLS CUI [1,2])
    C0029118 (UMLS CUI [2,1])
    C0332185 (UMLS CUI [2,2])
    Pharmaceutical Preparation Contraindicated Darunavir+Ritonavir | Pharmaceutical Preparation Contraindicated Raltegravir
    Item
    use of any medication contra-indicated with ritonavir-boosted darunavir or raltegravir
    boolean
    C0013227 (UMLS CUI [1,1])
    C1444657 (UMLS CUI [1,2])
    C1976853 (UMLS CUI [1,3])
    C0013227 (UMLS CUI [2,1])
    C1444657 (UMLS CUI [2,2])
    C1871526 (UMLS CUI [2,3])
    Lipid-lowering therapy
    Item
    use of lipid-lowering therapy
    boolean
    C0585943 (UMLS CUI [1])
    Diabetes Mellitus | Glucose measurement, fasting
    Item
    diabetes mellitus (fasting glucose >7.0mml/l or a prior diagnosis of diabetes)
    boolean
    C0011849 (UMLS CUI [1])
    C0202045 (UMLS CUI [2])
    Oral prednisolone U/day | Equivalent
    Item
    use of oral prednisolone > 7.5mg daily or equivalent
    boolean
    C0358513 (UMLS CUI [1,1])
    C0456683 (UMLS CUI [1,2])
    C0205163 (UMLS CUI [2])
    Pregnancy | Breast Feeding
    Item
    pregnancy or breast feeding
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Hypersensitivity Component Study Meal
    Item
    proven hypersensitivity to one or more components of the study meal
    boolean
    C0020517 (UMLS CUI [1,1])
    C1705248 (UMLS CUI [1,2])
    C0008972 (UMLS CUI [1,3])
    C1998602 (UMLS CUI [1,4])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video